• Vir Biotechnology SVP and Chief Accounting Officer Brent Sabatini sold 379 common shares on June 1, 2026.
• Shares sold at $9.45; holdings fell to 61,902 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-039938), on June 02, 2026, and is solely responsible for the information contained therein.